Grown Rogue International (GRUSF) Total Debt Growth (3y) (2012 - 2023)
Grown Rogue International (GRUSF) Total Debt Growth (3y) (2012 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | -2.21% |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -7.03% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.29% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 63.29% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 1,183.78% |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -7.76% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -14.15% |
| 10 | Grown Rogue International | 99.97 Mn | 92.67 Mn | 3.96 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2023 | -5.17% |
| Apr 30, 2021 | 185.88% |
| Oct 31, 2020 | 16.78% |
| Aug 31, 2018 | -17.42% |
| May 31, 2018 | -62.46% |
| Feb 28, 2018 | 27.26% |
| Nov 30, 2017 | 26.63% |
| May 31, 2017 | 68.52% |
| Feb 28, 2017 | -72.55% |
| Nov 30, 2015 | -103.20% |
| Aug 31, 2015 | 52.48% |
| May 31, 2015 | -33.43% |
| Feb 28, 2015 | -30.89% |
| Nov 30, 2014 | -30.31% |
| Aug 31, 2014 | -46.86% |
| May 31, 2014 | -80.60% |
| Feb 28, 2014 | 14.35% |
| Nov 30, 2013 | 23.17% |
| Aug 31, 2013 | -51.74% |
| May 31, 2013 | 138.52% |